PHARMA CO HAS LICENSE SUSPENDED AS VACCINE BLAMED FOR STERILIZATION OF 500,000 WOMEN & CHILDREN | WHAT REALLY HAPPENED


PHARMA CO HAS LICENSE SUSPENDED AS VACCINE BLAMED FOR STERILIZATION OF 500,000 WOMEN & CHILDREN

A state-sponsored forced sterilization on a massive scale has allegedly taken place in Africa according to opposition leaders and the public who are railing against the government. An industrial pharmaceutical laboratory has since had its license suspended by the Kenya Accreditation Service as a result of the controversy.

Kenya’s opposition leader Raila Odinga—who swore himself in as president on Tuesday—claimed that at least 500,000 young girls and women may be infertile, following a tetanus vaccine administered by the government in 2014 and 2015.

The controversy began coming to a head in 2016 when Agriq-Quest Ltd, a Nairobi-based pharmaceutical company got in a dispute with Kenya’s Ministry of Health over their tetanus and polio vaccinations. A group of Catholic doctors originally made the accusations claiming that the vaccines may contain a hormone that is dangerous to young women and can cause potential sterilization.

As the Agence de Presse Africaine reported:

Odinga said girls and women aged between 14 and 49 from the fastest growing populations in the country will not have children, because of a state-sponsored sterilization exercise that was sold to the country as a tetanus vaccination.

The Catholic Church was ignored when it mounted a strong but lonely campaign against the mass tetanus vaccination, after it raised concerns about the safety of the vaccine that was being used, he said.

At the time, the Catholic Church in Kenya claimed that the tetanus vaccine used by the government of Kenya and UN agencies was contaminated with a hormone (hCG) that can cause miscarriages and render some women sterile.

Webmaster's Commentary: 

Forced sterilization without consent?!?

IF these charges are true, the government in Nairobi has just opened itself up to the mother of all class action lawsuits

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA